Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitorsJeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, Ivana Vranic, Burak Sahin, Sara A Paciga, Zhenyu Wang, Craig Hyde, David A Martin
2 November 2022
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trialHuijing Wang, Ting Li, Fangfang Sun, Zhe Liu, Danting Zhang, Xiangyu Teng, Laurence Morel, Xiaodong Wang, Shuang Ye
26 October 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, Ulrike Held, Klaus Steigmiller, Cosimo Bruni, Fabio Cacciapaglia, Serena Vettori, Elise Siegert, Simona Rednic, Veronica Codullo, Paolo Airo, Yolanda Braun-Moscovici, Nicolas Hunzelmann, Maria Joao SalvadorSee the full list of authors
3 November 2022
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitisGerd R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Philip J Mease, Emma Guttman‑Yassky
8 February 2023
Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trialE Michael Shanahan, Tiffany K Gill, Elizabeth Briggs, Catherine L Hill, Gregory Bain, Timothy Morris
23 November 2022
Single-cell RNA-sequencing analysis reveals the molecular mechanism of subchondral bone cell heterogeneity in the development of osteoarthritisYan Hu, Jin Cui, Han Liu, Sicheng Wang, Qirong Zhou, Hao Zhang, Jiawei Guo, Liehu Cao, Xiao Chen, Ke Xu, Jiacan Su
8 September 2022
Methotrexate in pregnancy: still many unanswered questionsCorinna Weber-Schoendorfer, Orna Diav-Citrin
15 March 2023
Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smokingKaterina Chatzidionysiou, Daniela di Giuseppe, Jonas Soderling, Anca Catrina, Johan Askling
21 October 2022
Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre studyCharlotte Laurent, Laure Ricard, Yann Nguyen, Jean Jacques Boffa, Eric Rondeau, Grigorios Gerotziafas, Ismail Elalamy, Sophie Deriaz, Claire De Moreuil, Virginie Planche, Cathererine Johanet, Francois Millot, Olivier Fain, Arsène Mekinian
31 March 2023
Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based studyJing Zhang, Chenye Jin, Bing Ma, Hao Sun, Yanmei Chen, Ying Zhong, Cheng Han, Tingting Liu, Yongze Li
24 April 2023
VEXAS syndrome: a diagnostic puzzleNikolas Ruffer, Martin Krusche
2 August 2023
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, Arsène Mekinian, Zahir Amoura, Patrice Cacoub, Divi Cornec, Eric Hachulla, Pierre Quartier, Isabelle Melki, Christophe Richez, Raphaele Seror, Benjamin Terrier, Valérie Devauchelle-Pensec, Julien HenrySee the full list of authors
1 November 2022
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)Giovanni Adami, Angelo Fassio, Maurizio Rossini, Davide Bertelle, Francesca Pistillo, Camilla Benini, Ombretta Viapiana, Davide Gatti
4 January 2023
Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control studyJulie Merindol, Michael Levraut, Barbara Seitz-Polski, Lucas Morand, Nihal Martis
13 April 2023
Fibromyalgia and mortality: a systematic review and meta-analysisYulia Treister-Goltzman, Roni Peleg
10 July 2023
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide studyUlf Lindström, Daniela di Giuseppe, Sofia Exarchou, Gerd-Marie Alenius, Tor Olofsson, Eva Klingberg, Lennart Jacobsson, Johan Askling, Johan K Wallman
12 May 2023
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical careJuan Molina-Collada, Isabel Castrejón, Irene Monjo, Elisa Fernández-Fernández, Gabriela Torres Ortiz, Jose María Álvaro-Gracia, Eugenio de Miguel
24 April 2023
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung diseaseTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, So Takata, Yuko Abe, Takuro Nii, Tomoki Kuge, Shinichi Iwakoshi, Takayuki Shiroyama, Kotaro Miyake, Kazuyuki Tujino, Satoshi Tanizaki, Kota Iwahori, Haruhiko Hirata, Keisuke MikiSee the full list of authors
23 January 2023
Patient appropriateness for total knee arthroplasty and predicted probability of a good outcomeGillian A Hawker, Eric Bohm, Michael J Dunbar, Peter Faris, C Allyson Jones, Tom Noseworthy, Bheeshma Ravi, Linda J Woodhouse, Deborah A Marshall
17 April 2023
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael DiIorio, Kevin Kennedy, Jean W Liew, Michael S Putman, Emily Sirotich, Sebastian E Sattui, Gary Foster, Carly Harrison, Maggie J Larché, Mitchell Levine, Tarin T Moni, Lehana Thabane, Suleman Bhana, Wendy Costello, Rebecca GraingerSee the full list of authors
14 September 2022